Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China’s Bribery, Spotty Drug Distribution And IP Gaps Equals … Great Opportunities?

This article was originally published in PharmAsia News

Executive Summary

It is no secret that China is seen as a key growth market for the pharmaceutical industry. But as appealing as the country's skyrocketing market is to companies, many barriers to expansion, including IP concerns and a slowly improving drug distribution system - remain

You may also be interested in...

China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion

SHANGHAI - China issued its long-awaited three-year plan for its healthcare reform, and unveiled how the country will allocate RMB 850 billion ($124 billion) in the next three years

China Debates Changes In Government Price Ceilings On Drugs As Part Of Health System Reforms

BEIJING - As part of sweeping health system reforms that China is charting out for the next decade, the government is now mulling over how to change its price caps on medicines and how to formulate or approve pricing for virtually every drug on the market

China’s Supreme Court States Doctors Accepting Bribes Can Be Criminally Prosecuted

BEIJING - China's Supreme People's Court has issued a legal document that will make it easier and more likely for doctors accepting bribes to be prosecuted under the country's criminal law

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts